Atorvin 10mg (Atorvastatin Calcium Trihydrate)
Atorvastatin Calcium Trihydrate
Prescription medication
Korea Novartis Co., Ltd.
MFDS item code 200800081 · Notified 2008.01.03
This product's status changed to Approval withdrawn on 2023.06.29. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of hyperlipidemia (including familial hyperlipidemia in children); prevention of cardiovascular disease
This drug helps reduce the risk of cardiovascular diseases. It is particularly effective in reducing the risk of myocardial infarction, stroke, revascularization, and angina in adults with multiple risk factors or patients with type 2 diabetes. It also lowers the risk of myocardial infarction, stroke, and hospitalization due to congestive heart failure in patients with existing heart disease. In patients with hyperlipidemia, it is used as an adjunct to dietary therapy to improve cholesterol and triglyceride levels. It is also beneficial in lowering LDL-cholesterol levels in patients with familial heterozygous hypercholesterolemia. Overall, it is used to improve cardiovascular health and reduce the risks of associated diseases.
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This drug may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. However, patients requiring a greater reduction in LDL cholesterol may start at 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This drug is administered once daily within a dose range of 10 ~ 80 mg. The initial and maintenance doses of this drug should be individualized according to the patient's characteristics, taking into account treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or dose titration, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, LDL cholesterol is recommended for use when initiating treatment and evaluating response. However, if LDL cholesterol levels are unavailable, total cholesterol should be used to monitor the response to treatment. Patients with homozygous familial hypercholesterolemia The dose of this drug is 10 ~ 80 mg once daily. Administer it in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are unavailable. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dosage adjustment is necessary. ○ Elderly patients: The efficacy and safety in patients 70 years of age or older are generally similar to those in the general adult patient population.
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this drug once daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on administering doses of this drug greater than 20 mg in pediatric patients). The dose should be appropriately adjusted for each patient according to the recommended treatment goal. Adjust the dose at intervals of 4 weeks or longer.
This drug requires attention to muscle-related side effects. If you experience muscle pain or weakness, or markedly elevated levels of creatine kinase in the muscle, you should stop taking the medication immediately and consult your doctor. Particularly, if severe myopathy or rhabdomyolysis is suspected, caution is necessary for patients with risk factors as it may worsen kidney problems. This drug should not be administered to certain patients. For example, individuals allergic to this drug or its ingredients, those with active liver disease, pregnant or nursing women, and children under 10 years of age should not take this medication. Patients with genetic issues like galactose intolerance should also avoid it. Patients with liver or kidney function issues, alcohol addiction, hypothyroidism, or elderly patients should use it cautiously after consulting a doctor. Regular liver function tests are necessary due to the risk of liver dysfunction, hepatitis, or liver failure, and any abnormal symptoms should be reported to a doctor immediately. Additionally, if symptoms such as muscle pain, weakness, or fever appear during treatment, you should inform your doctor promptly, and blood tests may be necessary to check for muscle damage. This drug is contraindicated during pregnancy, and women of childbearing age should practice appropriate contraception while taking it. Nursing mothers should also avoid this medication. This drug may interact with other medications, so caution is needed, especially when used with certain antibiotics, antifungals, HIV treatments, and some antihypertensives. Consumption of grapefruit juice should also be avoided as it may increase the drug's blood concentration. There is no specific antidote for overdose, and treatment should be symptomatic while monitoring liver function and markers for muscle damage. This drug should be stored out of reach of children and kept in its original container for safety.
Not everyone experiences these, and they can vary from person to person.
This drug should be stored in a tightly sealed container to prevent exposure to air or moisture. It is important to maintain storage temperatures between 1°C and 30°C.
White or off-white, round, biconvex film-coated tablet engraved with HLA10 on one side
30 tablets (10 tablets/PTP x 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Atorvastatin Calcium Trihydrate
Prescription medication
Korea Novartis Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.